Sökning: onr:"swepub:oai:lup.lub.lu.se:2588ef81-ed7e-4640-84a3-36692e54036b" >
Evaluation of polyg...
Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers
-
- Kuchenbaecker, Karoline B. (författare)
- University of Cambridge,Wellcome Trust
-
- McGuffog, Lesley (författare)
- University of Cambridge
-
- Barrowdale, Daniel (författare)
- University of Cambridge
-
visa fler...
-
- Lee, Andrew (författare)
- University of Cambridge
-
- Soucy, Penny (författare)
- Centre hospitalier universitaire de Québec
-
- Dennis, Joe (författare)
- University of Cambridge
-
- Domchek, Susan M. (författare)
- Cochin Hospital
-
- Robson, Mark (författare)
- Memorial Sloan-Kettering Cancer Center
-
- Spurdle, Amanda B. (författare)
- QIMR Berghofer Medical Research Institute
-
- Ramus, Susan J. (författare)
- Garvan Institute of Medical Research,University of New South Wales
-
- Mavaddat, Nasim (författare)
- University of Cambridge
-
- Terry, Mary Beth (författare)
- Columbia University
-
- Neuhausen, Susan L. (författare)
- City of Hope National Medical Center
-
- Schmutzler, Rita Katharina (författare)
- University Hospital of Cologne
-
- Simard, Jacques (författare)
- Centre hospitalier universitaire de Québec
-
- Pharoah, Paul D.P. (författare)
- University of Cambridge
-
- Offit, Kenneth (författare)
- Memorial Sloan-Kettering Cancer Center
-
- Couch, Fergus J. (författare)
- Mayo Clinic Minnesota
-
- Chenevix-Trench, Georgia (författare)
- QIMR Berghofer Medical Research Institute
-
- Easton, Douglas F. (författare)
- University of Cambridge
-
- Antoniou, Antonis C. (författare)
- University of Cambridge
-
- Healey, Sue (författare)
- QIMR Berghofer Medical Research Institute
-
- Lush, Michael (författare)
- University of Cambridge
-
- Hamann, Ute (författare)
- German Cancer Research Centre
-
- Southey, Melissa (författare)
- University of Melbourne
-
- John, Esther M. (författare)
- Cancer Prevention Institute of California
-
- Chung, Wendy K. (författare)
- Columbia University
-
- Daly, Mary B. (författare)
- Fox Chase Cancer Center
-
- Buys, Saundra S. (författare)
- Huntsman Cancer Institute
-
- Goldgar, David E. (författare)
- University of Utah
-
- Dorfling, Cecilia M. (författare)
- University of Pretoria
-
- van Rensburg, Elizabeth J. (författare)
- University of Pretoria
-
- Ding, Yuan Chun (författare)
- City of Hope National Medical Center
-
- Ejlertsen, Bent (författare)
- Copenhagen University Hospital
-
- Gerdes, Anne Marie (författare)
- Copenhagen University Hospital
-
- Hansen, Thomas V.O. (författare)
- Copenhagen University Hospital
-
- Slager, Susan (författare)
- Mayo Clinic Minnesota
-
- Hallberg, Emily (författare)
- Mayo Clinic Minnesota
-
- Benitez, Javier (författare)
- Spanish National Cancer Research Center (CNIO),Biomedical Network on Rare Diseases (CIBERER)
-
- Osorio, Ana (författare)
- Biomedical Network on Rare Diseases (CIBERER)
-
- Cohen, Nancy (författare)
- City of Hope National Medical Center
-
- Lawler, William (författare)
- City of Hope National Medical Center
-
- Weitzel, Jeffrey N. (författare)
- City of Hope National Medical Center
-
- Peterlongo, Paolo (författare)
- IFOM - The FIRC Institute of Molecular Oncology
-
- Pensotti, Valeria (författare)
- Cogentech,IFOM - The FIRC Institute of Molecular Oncology
-
- Dolcetti, Riccardo (författare)
- University of Queensland,CRO (Centro di Riferimento Oncologico) Aviano National Cancer Institute
-
- Barile, Monica (författare)
- European Institute of Oncology
-
- Bonanni, Bernardo (författare)
- European Institute of Oncology
-
- Borg, Ake (författare)
- Lund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine
-
- Ehrencrona, Hans (författare)
- Lund University,Lunds universitet,Avdelningen för klinisk genetik,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Genetics,Department of Laboratory Medicine,Faculty of Medicine,Skåne University Hospital
-
visa färre...
-
(creator_code:org_t)
- 2017-03-09
- 2017
- Engelska.
-
Ingår i: Journal of the National Cancer Institute. - : Oxford University Press (OUP). - 0027-8874 .- 1460-2105. ; 109:7
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://academic.oup...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Genome-wide association studies (GWAS) have identified 94 common single-nucleotide polymorphisms (SNPs) associated with breast cancer (BC) risk and 18 associated with ovarian cancer (OC) risk. Several of these are also associated with risk of BC or OC for women who carry a pathogenic mutation in the high-risk BC and OC genes BRCA1 or BRCA2. The combined effects of these variants on BC or OC risk for BRCA1 and BRCA2 mutation carriers have not yet been assessed while their clinical management could benefit from improved personalized risk estimates. Methods: We constructed polygenic risk scores (PRS) using BC and OC susceptibility SNPs identified through population-based GWAS: for BC (overall, estrogen receptor [ER]-positive, and ER-negative) and for OC. Using data from 15 252 female BRCA1 and 8211 BRCA2 carriers, the association of each PRS with BC or OC risk was evaluated using a weighted cohort approach, with time to diagnosis as the outcome and estimation of the hazard ratios (HRs) per standard deviation increase in the PRS. Results: The PRS for ER-negative BC displayed the strongest association with BC risk in BRCA1 carriers (HR = 1.27, 95% confidence interval [CI] = 1.23 to 1.31, P = 8.2 × 10-53). InBRCA2 carriers, the strongest association with BC risk was seen for the overall BCPRS (HR = 1.22, 95% CI = 1.17 to 1.28, P = 7.2 × 10-20). The OC PRS was strongly associated with OC risk for both BRCA1 and BRCA2 carriers. These translate to differences in absolute risks (more than 10% in each case) between the top and bottom deciles of the PRS distribution; for example, the OC risk was 6% by age 80 years for BRCA2 carriers at the 10th percentile of the OC PRS compared with 19% risk for those at the 90th percentile of PRS. Conclusions: BC and OC PRS are predictive of cancer risk in BRCA1 and BRCA2 carriers. Incorporation of the PRS into risk prediction models has promise to better inform decisions on cancer risk management.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Kuchenbaecker, K ...
-
McGuffog, Lesley
-
Barrowdale, Dani ...
-
Lee, Andrew
-
Soucy, Penny
-
Dennis, Joe
-
visa fler...
-
Domchek, Susan M ...
-
Robson, Mark
-
Spurdle, Amanda ...
-
Ramus, Susan J.
-
Mavaddat, Nasim
-
Terry, Mary Beth
-
Neuhausen, Susan ...
-
Schmutzler, Rita ...
-
Simard, Jacques
-
Pharoah, Paul D. ...
-
Offit, Kenneth
-
Couch, Fergus J.
-
Chenevix-Trench, ...
-
Easton, Douglas ...
-
Antoniou, Antoni ...
-
Healey, Sue
-
Lush, Michael
-
Hamann, Ute
-
Southey, Melissa
-
John, Esther M.
-
Chung, Wendy K.
-
Daly, Mary B.
-
Buys, Saundra S.
-
Goldgar, David E ...
-
Dorfling, Cecili ...
-
van Rensburg, El ...
-
Ding, Yuan Chun
-
Ejlertsen, Bent
-
Gerdes, Anne Mar ...
-
Hansen, Thomas V ...
-
Slager, Susan
-
Hallberg, Emily
-
Benitez, Javier
-
Osorio, Ana
-
Cohen, Nancy
-
Lawler, William
-
Weitzel, Jeffrey ...
-
Peterlongo, Paol ...
-
Pensotti, Valeri ...
-
Dolcetti, Riccar ...
-
Barile, Monica
-
Bonanni, Bernard ...
-
Borg, Ake
-
Ehrencrona, Hans
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Journal of the N ...
- Av lärosätet
-
Lunds universitet